Lithium Ion

Lithium Ion

SCHEMBL7372953

O=C([O-])CCCOc1ccc(-c2ccccc2)cc1.[Li+]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 12/20 0.65
HDAC2 Q92769 12/20 0.65
HDAC3 O15379 10/20 0.65
HDAC4 P56524 10/20 0.65
HDAC7 Q8WUI4 10/20 0.65
HDAC10 Q969S8 10/20 0.65
HDAC11 Q96DB2 10/20 0.65
HDAC8 Q9BY41 10/20 0.65
HDAC6 Q9UBN7 10/20 0.65
HDAC9 Q9UKV0 10/20 0.65
HDAC5 Q9UQL6 10/20 0.65
FFAR4 Q5NUL3 4/20 0.61
FFAR1 O14842 2/20 0.61
MMP3 P08254 1/20 0.58
LTA4H P09960 1/20 0.51
LSS P48449 1/20 0.50
PPARG P37231 1/20 0.49
PPARD Q03181 1/20 0.49
PPARA Q07869 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL7365795 0.94 HDAC1 (0.75) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL9782295 0.90 HDAC1 (0.75) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL20214269 0.86 HDAC1 (0.56) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7049246 0.84 FFAR4 (0.75) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7049002 0.79 MMP2 (0.70) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7364711 0.79 HDAC3 (0.65) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL3189876 0.79 HDAC1 (0.63) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7044856 0.79 HDAC1 (0.88) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7394977 0.79 HDAC1 (1.00) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7368556 0.79 HDAC1 (1.00) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103192-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC4 HDAC1 1/4885HDAC2 7/4885HDAC3 6/4885
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC1 1/4885HDAC2 4/4885HDAC3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.